Search by Drug Name or NDC

    NDC 68462-0562-01 Diltiazem Hydrochloride 120 mg/1 Details

    Diltiazem Hydrochloride 120 mg/1

    Diltiazem Hydrochloride is a ORAL CAPSULE, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by GLENMARK PHARMACEUTICALS INC., USA. The primary component is DILTIAZEM HYDROCHLORIDE.

    Product Information

    NDC 68462-0562
    Product ID 68462-562_52b392c0-72cb-4a91-8d27-5cacdb8a7778
    Associated GPIs 34000010106920
    GCN Sequence Number 000570
    GCN Sequence Number Description diltiazem HCl CAP ER 12H 120 MG ORAL
    HIC3 A9A
    HIC3 Description CALCIUM CHANNEL BLOCKING AGENTS
    GCN 02321
    HICL Sequence Number 000182
    HICL Sequence Number Description DILTIAZEM HCL
    Brand/Generic Generic
    Proprietary Name Diltiazem Hydrochloride
    Proprietary Name Suffix n/a
    Non-Proprietary Name Diltiazem Hydrochloride
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE, EXTENDED RELEASE
    Route ORAL
    Active Ingredient Strength 120
    Active Ingredient Units mg/1
    Substance Name DILTIAZEM HYDROCHLORIDE
    Labeler Name GLENMARK PHARMACEUTICALS INC., USA
    Pharmaceutical Class Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA212317
    Listing Certified Through 2025-12-31

    Package

    NDC 68462-0562-01 (68462056201)

    NDC Package Code 68462-562-01
    Billing NDC 68462056201
    Package 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (68462-562-01)
    Marketing Start Date 2021-03-22
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 3.5045
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description DILTIAZEM 12HR ER 120 MG CAP
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis